Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idex (IEX) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Idex (IEX) over the last 17 years, with Q3 2025 value amounting to $75.4 million.

  • Idex's Shares Outstanding (Weighted Average) fell 39.63% to $75.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.4 million, marking a year-over-year decrease of 39.63%. This contributed to the annual value of $75.7 million for FY2024, which is 13.23% up from last year.
  • Idex's Shares Outstanding (Weighted Average) amounted to $75.4 million in Q3 2025, which was down 39.63% from $75.6 million recorded in Q2 2025.
  • In the past 5 years, Idex's Shares Outstanding (Weighted Average) ranged from a high of $76.1 million in Q1 2022 and a low of $75.4 million during Q3 2025
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $75.7 million (2024), whereas its average is $75.8 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 76.5% in 2021, then tumbled by 65.7% in 2023.
  • Quarter analysis of 5 years shows Idex's Shares Outstanding (Weighted Average) stood at $76.0 million in 2021, then dropped by 0.26% to $75.8 million in 2022, then decreased by 0.26% to $75.6 million in 2023, then grew by 0.13% to $75.7 million in 2024, then fell by 0.4% to $75.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $75.4 million in Q3 2025, compared to $75.6 million in Q2 2025 and $75.7 million in Q1 2025.